| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |